Search Browse Earnings

Cardio Diagnostics Holdings, Inc.

Nasdaq:CDIONasdaq:CDIOW

In Vitro & In Vivo Diagnostic Substances·CHICAGO, IL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$34,890

+104.5% YoY

FY 2025

Adj. EBITDA

-$8.3M

-23921.3% margin

FY 2025

Net Income

-$8.4M

-24028.2% margin

FY 2025

EPS (Diluted)

-$9.35

FY 2025

Stock Price

$2.29

-6.9%

2026-03-20

52W Range

$0.97 – $17.39

P/E Ratio

-0.2x

Market Cap

$6.8M

Cash

$0

FY 2025

Total Debt

—

Net Debt

$0

FY 2025

Enterprise Value

$6.8M

Debt / EBITDA

0.0x

FY 2025

EV / EBITDA

-0.8x

Employees

—